Login / Signup

Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.

Connor LynchMuzamil ArshadRohan R KatipallySean P PitrodaRalph R Weichselbaum
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sharing the burden of low-volume metastatic cancer between ICB and local treatments.
Keyphrases
  • squamous cell carcinoma
  • small cell lung cancer
  • social media
  • health information
  • risk factors
  • healthcare
  • stem cells
  • locally advanced
  • squamous cell
  • young adults
  • mesenchymal stem cells